Outcome by donor availability. Actuarial rates of DFS (A) and OS (B) of patients with ALL in CR1 according to sibling donor availability. OS and DFS are presented as from the day after completion and recovery of intensification chemotherapy, just before the start of consolidation by autologous SCT or allo-SCT.